Plain-English translation of NCT06244537 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new radiation therapy technique called MR-Linac in patients with advanced colon cancer that cannot be immediately removed by surgery. The treatment combines this specialized radiation therapy with chemotherapy drugs and surgery to see if it is safe and effective. Researchers want to understand whether this combination approach can help patients with this difficult-to-treat type of cancer.
Standard treatments for advanced colon cancer that cannot be surgically removed are limited, and outcomes for these patients are often poor. This trial is exploring whether this new radiation technique, combined with existing chemotherapy and surgery, might offer a better chance of controlling the cancer and helping patients live longer.
You likely qualify if…
You likely don't qualify if…
If you enroll, you would first receive a short course of specialized radiation therapy (5 treatments over one week). After that, you would receive chemotherapy for several cycles, followed by surgery to remove the cancer. Following surgery, you would receive additional chemotherapy cycles. Throughout this process, you would have regular visits for scans, blood tests, and check-ups to monitor your response to treatment and any side effects. The entire treatment course spans several months.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
China